Cite
Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer.
MLA
Huang, Jinyong, et al. “Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer.” Cancers, vol. 14, no. 19, Oct. 2022, p. 4714. EBSCOhost, https://doi.org/10.3390/cancers14194714.
APA
Huang, J., Du, M., Soupir, A., Wang, L., Tan, W., Kalari, K. R., Kilari, D., Park, J., Huang, C.-C., Kohli, M., & Wang, L. (2022). Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer. Cancers, 14(19), 4714. https://doi.org/10.3390/cancers14194714
Chicago
Huang, Jinyong, Meijun Du, Alex Soupir, Liewei Wang, Winston Tan, Krishna R. Kalari, Deepak Kilari, et al. 2022. “Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer.” Cancers 14 (19): 4714. doi:10.3390/cancers14194714.